{
    "clinical_study": {
        "@rank": "90655", 
        "arm_group": [
            {
                "arm_group_label": "isopropylmyristate oil", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo Soft gelatinous capsules filled with isopropylmyristate oil"
            }, 
            {
                "arm_group_label": "experimental", 
                "arm_group_type": "Active Comparator", 
                "description": "omega-3 1 gram three times daily for 6 months"
            }
        ], 
        "brief_summary": {
            "textblock": "The study aims at evaluating the effect of omega-3 on patients suffering recurrent oral\n      aphthous ulcers"
        }, 
        "brief_title": "Omega-3 and Quality of Life in Recurrent Aphthous Stomatitis Patients", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Recurrent Mouth Ulcers", 
        "condition_browse": {
            "mesh_term": [
                "Stomatitis", 
                "Stomatitis, Aphthous", 
                "Ulcer", 
                "Oral Ulcer"
            ]
        }, 
        "detailed_description": {
            "textblock": "In this study, we tested the hypothesis that the administration of omega 3  improve the\n      quality of life in patients suffering recurrent oral ulceration and improve associated\n      symptoms of pain in addition to reduction of ulcers episode."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Male and female patients older than 13 years of age\n\n          2. Presenting with 1 to 3 aphthous ulcers (less than 48 hours' duration) with a size no\n             greater than 5mm in diameter.\n\n          3. History of recurrent minor aphthous ulcer for at least one year with a frequency of\n             at least one outbreak every one month.\n\n          4. Normal sense of pain, without anesthesia or paresthesia.\n\n          5. Willingness to participate and sign the informed consent.\n\n        Exclusion Criteria:\n\n          -  1- Concurrent clinical conditions that could pose a health risk to the subjects\n             including serious heart, liver, or kidney dysfunctions.\n\n             2- Pregnancy and lactation. 3- Ulcers as a manifestation of systemic disorders such\n             as Ulcerative Colitis, Crohn's disease, Beh\u00e7et's syndrome or serious anemia.\n\n             4- Treatment with systemic steroids, immunomodulatory agents, antibiotics,\n             non-steroidal anti-inflammatory drugs (except occasional use for headaches) one month\n             prior to the study entry.\n\n             5- Treatment of the current ulcer with any topical or systemic medication. 6-\n             Attendance of any other clinical trials prior to 3 months of study entry."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01831453", 
            "org_study_id": "Dr. Amr Elkhouli 1962"
        }, 
        "intervention": [
            {
                "arm_group_label": "experimental", 
                "description": "polyunsaturated fatty acids(PUFAs) 1 gram three times per day for 6 months", 
                "intervention_name": "omega-3", 
                "intervention_type": "Drug", 
                "other_name": "fish oil"
            }, 
            {
                "arm_group_label": "isopropylmyristate oil", 
                "description": "soft gelatinous capsules filled with isopropylmyristate oil", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug", 
                "other_name": "isopropylmyristate oil"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "omega-3", 
            "recurrent aphthous stomatitis", 
            "quality of life"
        ], 
        "lastchanged_date": "April 10, 2013", 
        "link": {
            "description": "alzheimers", 
            "url": "http://www.alzheimers.org/"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Cairo", 
                    "country": "Egypt", 
                    "state": "Governarate of 6 of October", 
                    "zip": "11348"
                }, 
                "name": "October 6 university"
            }
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "Therapeutic Effect of Systemic Omega-3 Polyunsaturated Fatty Acids On Quality of Life in Patients Suffering From Recurrent Aphthous Stomatitis Unresponsive to Topical Therapy.", 
        "overall_official": {
            "affiliation": "October 6 University", 
            "last_name": "Amr M Elkhouli, ass prof", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measurement of oral health related quality of life (OHR-QoL),this parameter was carried out at baseline, and at 6 months of the study using the Arabic version of oral health impact profile-14 (OHIP-14) questionnaire.", 
            "measure": "quality of life", 
            "safety_issue": "No", 
            "time_frame": "six months"
        }, 
        "reference": {
            "PMID": "23481688", 
            "citation": "Hjorth E, Zhu M, Toro VC, Vedin I, Palmblad J, Cederholm T, Freund-Levi Y, Faxen-Irving G, Wahlund LO, Basun H, Eriksdotter M, Schultzberg M. Omega-3 Fatty Acids Enhance Phagocytosis of Alzheimer's Disease-Related Amyloid-\u03b242 by Human Microglia and Decrease Inflammatory Markers. J Alzheimers Dis. 2013 Mar 12. [Epub ahead of print]"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01831453"
        }, 
        "responsible_party": {
            "investigator_affiliation": "October 6 University", 
            "investigator_full_name": "Amr Moustafa Elkhouli", 
            "investigator_title": "Associate professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The measurements for treatment effectiveness included evaluation of pain associated with the ulcer(s) by means of visual analogue scales (VAS).", 
                "measure": "Pain associated with the ulcers", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "The time needed for the ulcer to heal", 
                "measure": "Duration of ulcers episode", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "The number of ulcers appears monthly in the mouth", 
                "measure": "The monthly number of ulcer outbreaks", 
                "safety_issue": "No", 
                "time_frame": "Monthly for six months"
            }
        ], 
        "source": "October 6 University", 
        "sponsors": {
            "collaborator": {
                "agency": "Tanta University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "October 6 University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}